# IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG

> **NCT01033617** · NA · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 20 (actual)

## Conditions studied

- Myocardial Infarct
- Heart Failure

## Interventions

- **PROCEDURE:** Injection of stem cells at time of coronary artery bypass grafting

## Key facts

- **NCT ID:** NCT01033617
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2014-12
- **Final completion:** 2016-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-10-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01033617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01033617, "IMPACT-CABG Trial: IMPlantation of Autologous CD133+ sTem Cells in Patients Undergoing CABG". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01033617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*